JP2007519753A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007519753A5 JP2007519753A5 JP2006551625A JP2006551625A JP2007519753A5 JP 2007519753 A5 JP2007519753 A5 JP 2007519753A5 JP 2006551625 A JP2006551625 A JP 2006551625A JP 2006551625 A JP2006551625 A JP 2006551625A JP 2007519753 A5 JP2007519753 A5 JP 2007519753A5
- Authority
- JP
- Japan
- Prior art keywords
- pyridinyl
- thiophenecarboxamide
- ethyl
- alkyl
- benzyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 NH 2 Chemical group 0.000 claims 25
- 125000000217 alkyl group Chemical group 0.000 claims 21
- 150000001875 compounds Chemical class 0.000 claims 12
- 229910052739 hydrogen Inorganic materials 0.000 claims 11
- 239000001257 hydrogen Substances 0.000 claims 10
- 125000003118 aryl group Chemical group 0.000 claims 9
- 125000003545 alkoxy group Chemical group 0.000 claims 6
- 229910052736 halogen Inorganic materials 0.000 claims 6
- 125000005843 halogen group Chemical group 0.000 claims 6
- 150000002367 halogens Chemical group 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 4
- 125000000623 heterocyclic group Chemical group 0.000 claims 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 4
- 125000002911 monocyclic heterocycle group Chemical group 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 3
- 125000004104 aryloxy group Chemical group 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 125000001072 heteroaryl group Chemical group 0.000 claims 3
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 2
- 125000006497 3-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1[H])C([H])([H])* 0.000 claims 2
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 125000002861 (C1-C4) alkanoyl group Chemical group 0.000 claims 1
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 claims 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 claims 1
- YNSCKPCDFIDINW-UHFFFAOYSA-N 3-[[2-[[1-[2-(dimethylamino)acetyl]-6-methoxy-4,4-dimethyl-2,3-dihydroquinolin-7-yl]amino]-7h-pyrrolo[2,3-d]pyrimidin-4-yl]amino]thiophene-2-carboxamide Chemical compound COC1=CC(C(CCN2C(=O)CN(C)C)(C)C)=C2C=C1NC(N=C1NC=CC1=1)=NC=1NC=1C=CSC=1C(N)=O YNSCKPCDFIDINW-UHFFFAOYSA-N 0.000 claims 1
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 claims 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000001318 4-trifluoromethylbenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])*)C(F)(F)F 0.000 claims 1
- FLWREGAOVVKATM-UHFFFAOYSA-N 5-pyridin-4-yl-n-[[3-(trifluoromethyl)phenyl]methyl]thiophene-2-carboxamide Chemical compound FC(F)(F)C1=CC=CC(CNC(=O)C=2SC(=CC=2)C=2C=CN=CC=2)=C1 FLWREGAOVVKATM-UHFFFAOYSA-N 0.000 claims 1
- UFYSIIQSAOSPRP-UHFFFAOYSA-N 5-pyridin-4-yl-n-[[4-(thiadiazol-4-yl)phenyl]methyl]thiophene-2-carboxamide Chemical compound C=1C=C(C=2C=CN=CC=2)SC=1C(=O)NCC(C=C1)=CC=C1C1=CSN=N1 UFYSIIQSAOSPRP-UHFFFAOYSA-N 0.000 claims 1
- FEMAMSZDYMIFHO-UHFFFAOYSA-N BrC1=C(CNC(=O)C=2SC(=CC2)C2=CC=NC=C2)C=CC=C1.C(C)OC1=C(CNC(=O)C=2SC(=CC2)C2=CC=NC=C2)C=CC=C1.C1(=CC=CC2=CC=CC=C12)CNC(=O)C=1SC(=CC1)C1=CC=NC=C1 Chemical compound BrC1=C(CNC(=O)C=2SC(=CC2)C2=CC=NC=C2)C=CC=C1.C(C)OC1=C(CNC(=O)C=2SC(=CC2)C2=CC=NC=C2)C=CC=C1.C1(=CC=CC2=CC=CC=C12)CNC(=O)C=1SC(=CC1)C1=CC=NC=C1 FEMAMSZDYMIFHO-UHFFFAOYSA-N 0.000 claims 1
- 125000002853 C1-C4 hydroxyalkyl group Chemical group 0.000 claims 1
- GIXCKNDPNJZTBV-UHFFFAOYSA-N N1=CC=C(C=C1)C1=CC=C(S1)C(=O)NCC1=NC=CC=C1.COC=1C=C(CNC(=O)C=2SC(=CC2)C2=CC=NC=C2)C=CC1.C1(=CC=CC=C1)CCNC(=O)C=1SC(=CC1)C1=CC=NC=C1 Chemical compound N1=CC=C(C=C1)C1=CC=C(S1)C(=O)NCC1=NC=CC=C1.COC=1C=C(CNC(=O)C=2SC(=CC2)C2=CC=NC=C2)C=CC1.C1(=CC=CC=C1)CCNC(=O)C=1SC(=CC1)C1=CC=NC=C1 GIXCKNDPNJZTBV-UHFFFAOYSA-N 0.000 claims 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 1
- 125000002619 bicyclic group Chemical group 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims 1
- UTGLLPISBOSSSP-UHFFFAOYSA-N n-(2-phenoxyethyl)-5-pyridin-4-ylthiophene-2-carboxamide Chemical compound C=1C=C(C=2C=CN=CC=2)SC=1C(=O)NCCOC1=CC=CC=C1 UTGLLPISBOSSSP-UHFFFAOYSA-N 0.000 claims 1
- OLKJZIBVEBBCCE-UHFFFAOYSA-N n-[(3-fluorophenyl)methyl]-5-pyridin-4-ylthiophene-2-carboxamide Chemical compound FC1=CC=CC(CNC(=O)C=2SC(=CC=2)C=2C=CN=CC=2)=C1 OLKJZIBVEBBCCE-UHFFFAOYSA-N 0.000 claims 1
- UHTMAZNMIBNNJH-UHFFFAOYSA-N n-[(3-iodophenyl)methyl]-5-pyridin-4-ylthiophene-2-carboxamide Chemical compound IC1=CC=CC(CNC(=O)C=2SC(=CC=2)C=2C=CN=CC=2)=C1 UHTMAZNMIBNNJH-UHFFFAOYSA-N 0.000 claims 1
- LJPDISQCQVBIIX-UHFFFAOYSA-N n-[(3-methoxyphenyl)methyl]-4,5-dipyridin-4-ylthiophene-2-carboxamide Chemical compound COC1=CC=CC(CNC(=O)C=2SC(=C(C=2)C=2C=CN=CC=2)C=2C=CN=CC=2)=C1 LJPDISQCQVBIIX-UHFFFAOYSA-N 0.000 claims 1
- NYXQARDWNLVKEO-UHFFFAOYSA-N n-[(4-iodophenyl)methyl]-5-pyridin-4-ylthiophene-2-carboxamide Chemical compound C1=CC(I)=CC=C1CNC(=O)C1=CC=C(C=2C=CN=CC=2)S1 NYXQARDWNLVKEO-UHFFFAOYSA-N 0.000 claims 1
- VCISBEJCMXTRJZ-UHFFFAOYSA-N n-[2-(2-bromophenyl)ethyl]-5-pyridin-4-ylthiophene-2-carboxamide Chemical compound BrC1=CC=CC=C1CCNC(=O)C1=CC=C(C=2C=CN=CC=2)S1 VCISBEJCMXTRJZ-UHFFFAOYSA-N 0.000 claims 1
- HXVGIXBNUXGSLV-UHFFFAOYSA-N n-[2-(2-chlorophenyl)ethyl]-5-pyridin-4-ylthiophene-2-carboxamide Chemical compound ClC1=CC=CC=C1CCNC(=O)C1=CC=C(C=2C=CN=CC=2)S1 HXVGIXBNUXGSLV-UHFFFAOYSA-N 0.000 claims 1
- FTEIRLNYDJAAMY-UHFFFAOYSA-N n-[2-(2-ethoxyphenyl)ethyl]-5-pyridin-4-ylthiophene-2-carboxamide Chemical compound CCOC1=CC=CC=C1CCNC(=O)C1=CC=C(C=2C=CN=CC=2)S1 FTEIRLNYDJAAMY-UHFFFAOYSA-N 0.000 claims 1
- KIRWVCOBPRINSB-UHFFFAOYSA-N n-[2-(2-fluorophenyl)ethyl]-5-pyridin-4-ylthiophene-2-carboxamide Chemical compound FC1=CC=CC=C1CCNC(=O)C1=CC=C(C=2C=CN=CC=2)S1 KIRWVCOBPRINSB-UHFFFAOYSA-N 0.000 claims 1
- QBTINFUQRCIFPN-UHFFFAOYSA-N n-[2-(2-methoxyphenyl)ethyl]-5-pyridin-4-ylthiophene-2-carboxamide Chemical compound COC1=CC=CC=C1CCNC(=O)C1=CC=C(C=2C=CN=CC=2)S1 QBTINFUQRCIFPN-UHFFFAOYSA-N 0.000 claims 1
- LDGMNZADCZUNOC-UHFFFAOYSA-N n-[2-(2-methylphenyl)ethyl]-5-pyridin-4-ylthiophene-2-carboxamide Chemical compound CC1=CC=CC=C1CCNC(=O)C1=CC=C(C=2C=CN=CC=2)S1 LDGMNZADCZUNOC-UHFFFAOYSA-N 0.000 claims 1
- KNHHWBDGXMIZKY-UHFFFAOYSA-N n-[2-(3-bromophenyl)ethyl]-5-pyridin-4-ylthiophene-2-carboxamide Chemical compound BrC1=CC=CC(CCNC(=O)C=2SC(=CC=2)C=2C=CN=CC=2)=C1 KNHHWBDGXMIZKY-UHFFFAOYSA-N 0.000 claims 1
- ZCNGUPCJOGKIMC-UHFFFAOYSA-N n-[2-(3-chlorophenyl)ethyl]-5-pyridin-4-ylthiophene-2-carboxamide Chemical compound ClC1=CC=CC(CCNC(=O)C=2SC(=CC=2)C=2C=CN=CC=2)=C1 ZCNGUPCJOGKIMC-UHFFFAOYSA-N 0.000 claims 1
- KADPJLAZRJJBLZ-UHFFFAOYSA-N n-[2-(3-fluorophenyl)ethyl]-5-pyridin-4-ylthiophene-2-carboxamide Chemical compound FC1=CC=CC(CCNC(=O)C=2SC(=CC=2)C=2C=CN=CC=2)=C1 KADPJLAZRJJBLZ-UHFFFAOYSA-N 0.000 claims 1
- IERMUUYUZYNTNV-UHFFFAOYSA-N n-[2-(3-methoxyphenyl)ethyl]-5-pyridin-4-ylthiophene-2-carboxamide Chemical compound COC1=CC=CC(CCNC(=O)C=2SC(=CC=2)C=2C=CN=CC=2)=C1 IERMUUYUZYNTNV-UHFFFAOYSA-N 0.000 claims 1
- YEARVZRDAHCEKE-UHFFFAOYSA-N n-[2-(3-methylphenyl)ethyl]-5-pyridin-4-ylthiophene-2-carboxamide Chemical compound CC1=CC=CC(CCNC(=O)C=2SC(=CC=2)C=2C=CN=CC=2)=C1 YEARVZRDAHCEKE-UHFFFAOYSA-N 0.000 claims 1
- ZWHNPJHDIQXJKC-UHFFFAOYSA-N n-[2-(4-chlorophenyl)ethyl]-5-pyridin-4-ylthiophene-2-carboxamide Chemical compound C1=CC(Cl)=CC=C1CCNC(=O)C1=CC=C(C=2C=CN=CC=2)S1 ZWHNPJHDIQXJKC-UHFFFAOYSA-N 0.000 claims 1
- ONMNVQFYJSDTSK-UHFFFAOYSA-N n-[2-(4-ethoxyphenyl)ethyl]-5-pyridin-4-ylthiophene-2-carboxamide Chemical compound C1=CC(OCC)=CC=C1CCNC(=O)C1=CC=C(C=2C=CN=CC=2)S1 ONMNVQFYJSDTSK-UHFFFAOYSA-N 0.000 claims 1
- AAWNVQYZVTTYED-UHFFFAOYSA-N n-[2-(4-fluorophenyl)ethyl]-5-pyridin-4-ylthiophene-2-carboxamide Chemical compound C1=CC(F)=CC=C1CCNC(=O)C1=CC=C(C=2C=CN=CC=2)S1 AAWNVQYZVTTYED-UHFFFAOYSA-N 0.000 claims 1
- GLXDXPJVBQNVCW-UHFFFAOYSA-N n-[2-(4-methoxyphenyl)ethyl]-5-pyridin-4-ylthiophene-2-carboxamide Chemical compound C1=CC(OC)=CC=C1CCNC(=O)C1=CC=C(C=2C=CN=CC=2)S1 GLXDXPJVBQNVCW-UHFFFAOYSA-N 0.000 claims 1
- LSJKTQNRBPFHOI-UHFFFAOYSA-N n-[2-(4-methylphenyl)ethyl]-5-pyridin-4-ylthiophene-2-carboxamide Chemical compound C1=CC(C)=CC=C1CCNC(=O)C1=CC=C(C=2C=CN=CC=2)S1 LSJKTQNRBPFHOI-UHFFFAOYSA-N 0.000 claims 1
- XNKDJYWEHKDRKM-UHFFFAOYSA-N n-[2-(4-phenoxyphenyl)ethyl]-5-pyridin-4-ylthiophene-2-carboxamide Chemical compound C=1C=C(C=2C=CN=CC=2)SC=1C(=O)NCCC(C=C1)=CC=C1OC1=CC=CC=C1 XNKDJYWEHKDRKM-UHFFFAOYSA-N 0.000 claims 1
- NKQBYWBQSXGNSU-UHFFFAOYSA-N n-benzyl-5-(1h-pyrazol-4-yl)thiophene-2-carboxamide Chemical compound C=1C=C(C2=CNN=C2)SC=1C(=O)NCC1=CC=CC=C1 NKQBYWBQSXGNSU-UHFFFAOYSA-N 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 125000001113 thiadiazolyl group Chemical group 0.000 claims 1
- 0 *c1c(*)[s]c(C(N(*)*)=O)c1 Chemical compound *c1c(*)[s]c(C(N(*)*)=O)c1 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54060504P | 2004-01-30 | 2004-01-30 | |
| PCT/US2005/003478 WO2005074642A2 (en) | 2004-01-30 | 2005-01-28 | Chemical compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007519753A JP2007519753A (ja) | 2007-07-19 |
| JP2007519753A5 true JP2007519753A5 (https=) | 2008-03-13 |
Family
ID=34837405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006551625A Pending JP2007519753A (ja) | 2004-01-30 | 2005-01-28 | 化合物 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20080293716A1 (https=) |
| EP (1) | EP1708697A4 (https=) |
| JP (1) | JP2007519753A (https=) |
| WO (1) | WO2005074642A2 (https=) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA06010520A (es) * | 2004-03-30 | 2007-03-26 | Chiron Corp | Derivados de tiofeno sustituidos como agentes anticancerosos. |
| EP1907385A4 (en) * | 2005-07-26 | 2009-05-06 | Smithkline Beecham Corp | LINKS |
| WO2007016292A2 (en) * | 2005-07-27 | 2007-02-08 | Vertex Pharmaceuticals Incorporated | Heterocyclic amides as biofilm modulators |
| US8211919B2 (en) | 2005-09-02 | 2012-07-03 | Astellas Pharma Inc. | Amide derivatives as rock inhibitors |
| AU2007208358A1 (en) | 2006-01-23 | 2007-08-02 | Vertex Pharmaceuticals Incorporated | Thiophene-carboxamides useful as inhibitors of protein kinases |
| EP2418210A1 (en) | 2006-04-13 | 2012-02-15 | Vertex Pharmceuticals Incorporated | Thiophene-carboxamides useful as inhibitors of protein kinases |
| ATE478865T1 (de) | 2006-05-12 | 2010-09-15 | Vertex Pharma | Selektive rock-proteinkinasehemmer und ihre verwendung |
| AU2007268056A1 (en) | 2006-05-23 | 2007-12-06 | Vertex Pharmaceuticals Incorporated | Thiophene-carboxamides useful as inhibitors of protein kinases |
| JP2009538309A (ja) | 2006-05-23 | 2009-11-05 | バーテックス ファーマシューティカルズ インコーポレイテッド | プロテインキナーゼのインヒビターとして有用なチオフェンカルボキサミド |
| UY30892A1 (es) | 2007-02-07 | 2008-09-02 | Smithkline Beckman Corp | Inhibidores de la actividad akt |
| JP5451602B2 (ja) * | 2007-06-08 | 2014-03-26 | アッヴィ・インコーポレイテッド | キナーゼ阻害薬としての５−ヘテロアリール置換インダゾール類 |
| US8648069B2 (en) | 2007-06-08 | 2014-02-11 | Abbvie Inc. | 5-substituted indazoles as kinase inhibitors |
| JP5581219B2 (ja) | 2008-01-25 | 2014-08-27 | ミレニアム ファーマシューティカルズ， インコーポレイテッド | チオフェンおよびホスファチジルイノシトール３−キナーゼ（ｐｉ３ｋ）阻害薬としてのその使用 |
| US8796314B2 (en) | 2009-01-30 | 2014-08-05 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| WO2010090716A1 (en) | 2009-01-30 | 2010-08-12 | Millennium Pharmaceuticals, Inc. | Heteroaryls and their use as pi3k inhibitors |
| US9090601B2 (en) | 2009-01-30 | 2015-07-28 | Millennium Pharmaceuticals, Inc. | Thiazole derivatives |
| WO2010093885A1 (en) * | 2009-02-12 | 2010-08-19 | Glaxosmithkline Llc | Inhibitors of akt activity |
| NZ600449A (en) | 2009-12-16 | 2014-10-31 | Neuropore Therapies Inc | Compound suitable for the treatment of synucleopathies |
| US8859768B2 (en) | 2010-08-11 | 2014-10-14 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| WO2012021611A1 (en) | 2010-08-11 | 2012-02-16 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| MX2013001660A (es) | 2010-08-11 | 2013-06-03 | Millenium Pharmaceuticals Inc | Heteroarilos y usos de los mismos. |
| TW201307309A (zh) | 2010-10-13 | 2013-02-16 | Millennium Pharm Inc | 雜芳基化合物及其用途 |
| EP2991980B1 (en) * | 2013-04-30 | 2019-01-02 | Glaxosmithkline Intellectual Property (No. 2) Limited | Enhancer of zeste homolog 2 inhibitors |
| WO2014177699A1 (en) * | 2013-05-03 | 2014-11-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Rhoa (rock) inhibitors for the treatment of enflammatory bowel disease |
| EP4088719A1 (en) | 2015-10-13 | 2022-11-16 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Methods and pharmaceutical compositions for the treatment of retinal capillary non-perfusion |
| WO2017064119A1 (en) | 2015-10-13 | 2017-04-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of retinal capillary non-perfusion |
| EP3388428B1 (en) * | 2015-12-07 | 2021-08-04 | Suzhou Sinovent Pharmaceuticals Company | Five-membered heterocyclic amides wnt pathway inhibitor |
| BR112020022220A2 (pt) * | 2018-06-01 | 2021-02-02 | Autophagysciences Inc. | novo composto e composição farmacêutica compreendendo o mesmo |
| WO2021007477A1 (en) | 2019-07-11 | 2021-01-14 | E-Scape Bio, Inc. | Indazoles and azaindazoles as lrrk2 inhibitors |
| CN111333636B (zh) * | 2020-04-10 | 2021-12-17 | 福建太平洋制药有限公司 | 噻唑酰胺类衍生物及其在抗肿瘤药物中的应用 |
| WO2025224050A1 (en) | 2024-04-22 | 2025-10-30 | Institut National de la Santé et de la Recherche Médicale | Methods of treatment of patients suffering from hypomelanosis of ito |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0712397B1 (en) * | 1993-08-06 | 1999-04-21 | Smithkline Beecham Plc | Amide derivatives as 5ht1d receptor antagonists |
| ATE334975T1 (de) * | 1997-05-30 | 2006-08-15 | Takeda Pharmaceutical | Sulfonamidderivate, ihre herstellung und verwendung |
| US5886191A (en) * | 1997-08-18 | 1999-03-23 | Dupont Pharmaceuticals Company | Amidinoindoles, amidinoazoles, and analogs thereof |
| EP1109918B1 (en) | 1998-06-24 | 2006-10-04 | University of Dundee | Mitogen- and stress-activated protein kinases that contain two kinase domains and uses thereof |
| CA2338697A1 (en) * | 1998-07-28 | 2000-02-10 | Smithkline Beecham Corporation | Compounds and methods |
| JP2002047272A (ja) * | 2000-07-26 | 2002-02-12 | Dai Ichi Seiyaku Co Ltd | ポリアミンアミド誘導体 |
| GB0209715D0 (en) * | 2002-04-27 | 2002-06-05 | Astrazeneca Ab | Chemical compounds |
| MXPA06010520A (es) * | 2004-03-30 | 2007-03-26 | Chiron Corp | Derivados de tiofeno sustituidos como agentes anticancerosos. |
| KR20070002081A (ko) * | 2004-04-02 | 2007-01-04 | 버텍스 파마슈티칼스 인코포레이티드 | Ｒｏｃｋ 및 기타 단백질 키나아제의 억제제로서 유용한아자인돌 |
-
2005
- 2005-01-28 US US10/597,475 patent/US20080293716A1/en not_active Abandoned
- 2005-01-28 JP JP2006551625A patent/JP2007519753A/ja active Pending
- 2005-01-28 EP EP05722720A patent/EP1708697A4/en not_active Withdrawn
- 2005-01-28 WO PCT/US2005/003478 patent/WO2005074642A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007519753A5 (https=) | ||
| US20220282254A1 (en) | P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd | |
| JP2010513444A5 (https=) | ||
| JP2013500267A5 (https=) | ||
| JP2010533158A5 (https=) | ||
| RU2016102137A (ru) | Первичные карбоксамиды в качестве ингибиторов bik | |
| JP2007519754A5 (https=) | ||
| JP2016523911A5 (https=) | ||
| JP2012533630A (ja) | フラビウイルス科ウイルスの阻害剤 | |
| JP2018530571A5 (https=) | ||
| TW200815427A (en) | Organic compounds | |
| JP2007505091A5 (https=) | ||
| TW200534853A (en) | Synergistic methods and compositions for treating cancer | |
| MX2013005124A (es) | Estimuladores de la gcs. | |
| CA2391643A1 (en) | Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors | |
| RU2009114857A (ru) | Гетероциклические органические соединения | |
| TW200413318A (en) | Chemical compounds | |
| HRP20130143T1 (hr) | Derivati pirazolo piridina kao inhibitori nadph oksidaze | |
| JP2007513915A5 (https=) | ||
| JP2012136550A (ja) | Ｊｎｋ阻害剤およびスクロスポリンを含んでなる組成物 | |
| JP2019505595A5 (https=) | ||
| US10537560B2 (en) | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD | |
| JP2008502614A5 (https=) | ||
| JP2005516924A5 (https=) | ||
| RU2324685C2 (ru) | Производные тиазола, способ их получения и применение, фармацевтическая композиция, обладающая свойствами антагонистов рецепторов npy |